ArticleBioinformation2025
Comparative assessment of oral placement therapy combining B-ARM chewing tube and speech therapy for children with autism spectrum disorders.
Article in Bioinformation, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The impact of oral placement therapy using B-ARM chewing tube along with speech therapy in terms of muscle tonicity and drooling in children with Autism spectrum disorders (ASD) is of interest. 30 children with ASD in the age group of 5-10 years were selected for the study. They were divided into two equal group with speech therapy B-ARM chewy tube provided to experimental group (N=15), while the control group (N=15) was given only speech therapy. The muscle tonicity and drooling of saliva were assessed for both groups using surface electromyography and the drooling severity scale, respectively before and after 3 months. Thus, B-ARM was recommended as an effective tool for oral placement therapy for children with ASD.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.